Last reviewed · How we verify
NCT05752058
Risk Factors for Early Acute Lung Injury After Liver Transplantation in Children
trial in Acute Lung Injury in 300 participants. Status unknown.
30 September 2024
Quick facts
| Lead sponsor | Tianjin First Central Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 1 August 2023 |
| Primary completion | 30 September 2024 |
| Estimated completion | 31 December 2024 |
Conditions studied
- Acute Lung Injury — all drugs for Acute Lung Injury →
- Liver Transplantation — all drugs for Liver Transplantation →
- Risk Factors — all drugs for Risk Factors →
Sponsor
Tianjin First Central Hospital
Who can join
Adults 3 Months to 2, any sex, with Acute Lung Injury or Liver Transplantation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to identify the risk factors for early acute lung injury (ALI) after liver transplantation in children .The main questions it aims to answer are what the risk factors are for early ALI in children and to evaluate the predictive value for the development of ALI.Participants will be divided into non-ALI group and ALI group according to whether they had ALI in a week after liver transplantation.Researchers will compare the difference between the two groups and use multivariate logistic regression analysis to screen the risk factors of ALI, and receiver operating characteristic(ROC) curve was used to evaluate the predictive efficacy of risk factors.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05752058
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Lung Injury
Currently open trials in the same condition.
- NCT05704166 — PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients · Phase 2 · recruiting
Other Tianjin First Central Hospital trials
Trials by the same sponsor.
- NCT06598228 — Acute Kidney Injury and Recovery Mode in Pediatric Liver Transplantation · completed
- NCT05926076 — COVID-19 Infection · unknown
- NCT05807802 — FSTL1 and PPCs on Pediatric Within LDLT:a Prospective Cohort Analysis · unknown
- NCT05783518 — Effect of Desflurane on Pediatric Acute Respiratory Distress Syndrome After Living Donor Liver Transplant Recipients · Phase 4 · unknown
- NCT03904485 — Assessment of Myocardial Injury in Simultaneous Pancreas and Kidney Transplantation · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05752058 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tianjin First Central Hospital
- Last refreshed: 16 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05752058.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing